3
Announcements
Trials
Browse
Landscape
Status
Completed
2
Sponsor Class
INDUSTRY
2
Study Type
Observational
2
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
2
Conditions
Colorectal Neoplasms
4
Stomach Neoplasms
2
Cardiovascular Diseases
2
Recurrence
1
Pulmonary Embolism
1
Pancreatic Neoplasms
1
Neoplasms
1
Lung Neoplasms
1
Hemorrhage
1
Gastrointestinal Neoplasms
1
Esophageal Neoplasms
1
Carcinoma, Renal Cell
1
Carcinoma, Non-Small-Cell Lung
1
Interventions
Gastrectomy
13
Observation
12
Gastroscopy
11
Drug Therapy
9
Surveys and Questionnaires
8
Surgical Procedures, Operative
8
Endoscopic Mucosal Resection
8
Paclitaxel
6
Immune Checkpoint Inhibitors
6
Blood Specimen Collection
6
Tomography, X-Ray Computed
5
Oxaliplatin
5
Trastuzumab
4
Ramucirumab
4
Irinotecan
4
Immunotherapy
4
Hyperthermic Intraperitoneal Chemotherapy
4
Cisplatin
4
Biopsy
4
tislelizumab
3
S 1 (combination)
3
Robotic Surgical Procedures
3
Radiotherapy
3
Positron Emission Tomography Computed Tomography
3
Nivolumab
3
Neoadjuvant Therapy
3
Laparoscopy
3
Interviews as Topic
3
Capecitabine
3
taxane
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Observational
×
Stomach Neoplasms
×
Aspirin
×
Clear all
NCT04081831
2022-04-19
ENgAGE-HK
Bayer
Completed
99,999 enrolled
NCT03743883
2020-06-01
ENgAGE-UK
Bayer
Completed
99,999 enrolled